Farringdon Capital Ltd. Purchases Shares of 756 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Farringdon Capital Ltd. bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 756 shares of the medical equipment provider's stock, valued at approximately $395,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Atala Financial Inc purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at about $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical during the fourth quarter valued at about $28,000. Hurley Capital LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $28,000. Finally, Summit Securities Group LLC purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Up 0.3 %

Shares of ISRG stock traded up $1.40 during trading hours on Friday, reaching $482.74. 1,618,989 shares of the company's stock were exchanged, compared to its average volume of 1,589,481. Intuitive Surgical, Inc. has a 1 year low of $364.31 and a 1 year high of $616.00. The stock has a market cap of $171.94 billion, a PE ratio of 75.31, a PEG ratio of 5.85 and a beta of 1.55. The stock's fifty day moving average price is $522.23 and its two-hundred day moving average price is $532.71.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now directly owns 5,758 shares of the company's stock, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Wells Fargo & Company increased their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Citigroup boosted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. Finally, Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating for the company in a research note on Tuesday, March 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $611.81.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.